<DOC>
	<DOCNO>NCT02392078</DOCNO>
	<brief_summary>The NeuroBlate® System ( NBS ) minimally invasive robotic laser thermotherapy tool manufacture Monteris Medical . Since receive FDA clearance April 2013 , NBS use 300 procedure conduct approximately 20 leading institution across United States . This prospective , multi-center registry include data collection 12 month evaluate procedural success , local control failure rate , QoL 1,000 patient 50 site .</brief_summary>
	<brief_title>Laser Ablation Abnormal Neurological Tissue Using Robotic NeuroBlate System</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1 . Patient legally authorize representative provide write authorization and/or consent per institution geographical requirement 2 . Patient undergo thermal therapy NeuroBlate® System treatment neurological disorder 1 . Patient , expect inaccessible followup 2 . Patient meet exclusion criterion require local law ( e.g . age ) 3 . Other concurrent medical condition ( chronic acute nature ) opinion investigator may prevent participation otherwise render patient ineligibility study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Procedural Success</keyword>
	<keyword>Progression</keyword>
	<keyword>Quality Life</keyword>
</DOC>